Nobuteru Usuda Selected Research

Nobuteru Usuda Research Topics

Disease

9	Chronic Subdural Hematoma 01/2020 - 06/2011
7	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2018 - 02/2006
5	Neoplasms (Cancer) 11/2010 - 01/2002
4	Brain Ischemia (Cerebral Ischemia) 12/2018 - 11/2004
3	Ischemia 12/2018 - 09/2002
3	Inflammation (Inflammations) 12/2017 - 07/2013
2	Schizophrenia (Dementia Praecox) 12/2017 - 07/2013
2	Cholangiocarcinoma 02/2010 - 04/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 05/2008 - 02/2006
1	Cognitive Dysfunction 12/2018
1	Intellectual Disability (Idiocy) 12/2017
1	Brain Injuries (Brain Injury) 08/2015
1	Intervertebral Disc Displacement (Herniated Disc) 05/2014
1	Hematoma 12/2012
1	Colorectal Neoplasms (Colorectal Cancer) 11/2010
1	Neoplasm Metastasis (Metastasis) 11/2010
1	Disease Progression 11/2010
1	Carcinogenesis 09/2010
1	Hemangiosarcoma (Angiosarcoma) 02/2010
1	Hepatomegaly 01/2007
1	Paralysis (Palsy) 01/2007
1	Body Weight (Weight, Body) 12/2005
1	Obesity 12/2005
1	Proteinuria 12/2005
1	Hypertension (High Blood Pressure) 12/2005
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2005
1	Ischemic Stroke 11/2004
1	Huntington Disease (Huntington's Disease) 03/2003
1	Starvation 07/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2017 - 02/2006
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2018 - 09/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 02/2006
3	Proteins (Proteins, Gene)FDA Link 07/2013 - 03/2003
3	Radioisotopes (Radionuclides)IBA 09/2010 - 04/2009
2	Carrier Proteins (Binding Protein)IBA 12/2017 - 07/2013
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 08/2015 - 09/2002
2	Mitogen-Activated Protein KinasesIBA 07/2015 - 09/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2012 - 11/2004
2	Thorium Dioxide (Thorotrast)IBA 02/2010 - 04/2009
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2009 - 05/2008
2	PPAR alphaIBA 01/2007 - 07/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2007 - 07/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2018
1	CaspasesIBA 11/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Janus KinasesIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2016
1	Neuroprotective AgentsIBA 08/2015
1	Indicators and Reagents (Reagents)IBA 08/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2014
1	Chemokine CCL26IBA 08/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013
1	ParvalbuminsIBA 07/2013
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 07/2013
1	NAD (NADH)IBA 07/2013
1	ProteomeIBA 07/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2012
1	STAT1 Transcription FactorIBA 12/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 06/2011
1	E-SelectinIBA 11/2010
1	SuspensionsIBA 02/2010
1	JNK Mitogen-Activated Protein KinasesIBA 09/2007
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2007
1	ZoxazolamineIBA 01/2007
1	pentosidineIBA 12/2005
1	Advanced Glycation End ProductsIBA 12/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 11/2004
1	Adenosine Triphosphate (ATP)IBA 07/2002
1	LigandsIBA 01/2002
1	Phosphotransferases (Kinase)IBA 01/2002
1	PPAR gammaIBA 01/2002
1	CollagenIBA 01/2002
1	Troglitazone (Rezulin)FDA Link 01/2002

Therapy/Procedure

1	Trephining 01/2017
1	Caloric Restriction 12/2005
1	Therapeutics 01/2002